Tech Company Financing Transactions

MIMETAS Funding Round

Bruker participated in a funding round for MIMETAS. The round was announced by the company on 8/10/2026.

Transaction Overview

Company Name
Announced On
8/10/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to scale its platforms, expand global availability of its human tissue models, and develop integrated product and service workflows that connect its systems with Bruker's technologies.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
De Limes 7,? Biopartner Building 5?
Oegstgeest?, 2342 DH
The Netherlands
Email Address
Overview
Every year, drugs fail in late-stage trials because traditional models can't accurately predict how they'll function in humans. At MIMETAS, we're changing that. We create the world's most advanced human tissue and disease models using our organ-on-a-chip technology -- enabling faster development of safer and more effective therapies that improve patient lives. Our mission is to develop the world's most advanced in vitro models to support the creation of breakthrough medicines for today's unmet medical needs. We envision a future where every new medicine is developed and tested using advanced 3D human tissue and disease models -- accelerating innovation, lowering costs, and saving lives.
Profile
MIMETAS LinkedIn Company Profile
Social Media
MIMETAS Company Twitter Account
Company News
MIMETAS News
Facebook
MIMETAS on Facebook
YouTube
MIMETAS on YouTube

Management Team

Title
Name
Email & Social
Chairman
Dhaval Patel
  Dhaval Patel LinkedIn Profile  Dhaval Patel Twitter Account  Dhaval Patel News  Dhaval Patel on Facebook
Chief Executive Officer
Jos Joore
  Jos Joore LinkedIn Profile  Jos Joore Twitter Account  Jos Joore News  Jos Joore on Facebook
Chief Executive Officer
Paul Vulto
  Paul Vulto LinkedIn Profile  Paul Vulto Twitter Account  Paul Vulto News  Paul Vulto on Facebook
Chief Technical Officer
Bas Trietsch
  Bas Trietsch LinkedIn Profile  Bas Trietsch Twitter Account  Bas Trietsch News  Bas Trietsch on Facebook
President
Yoko Ejiri
  Yoko Ejiri LinkedIn Profile  Yoko Ejiri Twitter Account  Yoko Ejiri News  Yoko Ejiri on Facebook
VP - Bus. Development
Henriette Lanz
  Henriette Lanz LinkedIn Profile  Henriette Lanz Twitter Account  Henriette Lanz News  Henriette Lanz on Facebook
VP - Bus. Development
Remko van Vught
  Remko van Vught LinkedIn Profile  Remko van Vught Twitter Account  Remko van Vught News  Remko van Vught on Facebook
VP - Sales
Mieke Doornbos
  Mieke Doornbos LinkedIn Profile  Mieke Doornbos Twitter Account  Mieke Doornbos News  Mieke Doornbos on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/10/2026: Diald AI venture capital transaction
Next: 8/10/2026: Edgify venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary